Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Pharmaceutical Strategies (NPS) is a specialized consulting firm that provides strategic advisory services to the life sciences industry, focusing on market access, pricing, and reimbursement. The company assists pharmaceutical and biotechnology firms in navigating complex regulatory and commercial landscapes to optimize product launches and lifecycle management. Their expertise spans across global markets, helping clients develop value propositions and evidence-based strategies to secure favorable payer coverage. Led by industry veterans, NPS bridges the gap between clinical development and commercial success through data-driven insights. The firm is particularly noted for its deep understanding of healthcare law and policy, providing clients with a competitive edge in highly regulated environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Pharmaceutical Strategies.